| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8756 |
| Human Intestinal Absorption | HIA+ | 0.9910 |
| Caco-2 Permeability | Caco2+ | 0.6516 |
| P-glycoprotein Substrate | Non-substrate | 0.5108 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8869 |
| Non-inhibitor | 0.9760 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8448 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6801 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7848 |
| CYP450 2D6 Substrate | Non-substrate | 0.6253 |
| CYP450 3A4 Substrate | Non-substrate | 0.6302 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5000 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9094 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.5128 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8440 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8737 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7319 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9024 |
| Non-inhibitor | 0.7292 |
| AMES Toxicity | Non AMES toxic | 0.8842 |
| Carcinogens | Non-carcinogens | 0.7367 |
| Fish Toxicity | High FHMT | 0.9404 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9936 |
| Honey Bee Toxicity | Low HBT | 0.6798 |
| Biodegradation | Not ready biodegradable | 0.9740 |
| Acute Oral Toxicity | III | 0.6754 |
| Carcinogenicity (Three-class) | Non-required | 0.7261 |